Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Robinhood Markets, Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Robinhood Markets, Inc. trades at $99.16 (market cap $99.37B). The key difference: Robinhood Markets, Inc. is far larger — about 25.2× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Robinhood Markets, Inc. for 75 Days on average.
| EWTX | HOOD | |
|---|---|---|
Market Cap | $3.94B | $99.37B |
Volume | 810,104 | 14,977,713 |
Sector | Health | Financials |
52-Week High | $48.35 | $147.08 |
52-Week Low | $14.89 | $65.16 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $3.48B | $105.91B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Robinhood (HOOD) trades at $101.08, down 7.45% in the last session, as investors digest mixed quarterly results. The stock shows neutral technical signals with support at $108 and resistance at $110. Fundamentally, the company demonstrates strong revenue growth from $3.0B in 2024 to $4.5B in 2025, with robust 42% net margins, though valuation multiples remain elevated with a P/E of 48.9. Recent announcements include plans for 24/7 stock trading and expanded crypto offerings.
Outlook remains positive with 77% analyst buy ratings and a $138.60 consensus price target implying 37% upside. Key opportunities include market share gains from new trading features, while risks involve high valuation sensitivity and regulatory scrutiny over leveraged crypto products. The Q3 2026 earnings report on October 27 will be critical for validating growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
